速来：全国肝炎检测宣传设计大赛进行中

▼

本次宣传设计大赛的主题为“肝炎检测”。参赛的设计作品需要以增强公众检测乙肝和丙肝意识为目标，动员人们参加肝炎检测，消除对肝炎患者的歧视，提高肝炎检测率。

• 征稿阶段： 

      2017年3月至2017年4月20日

• 作品评选：

      2017年5月至2017年7月下旬

• 获奖结果公布：

      2017年“世界肝炎日”（7月28日）

• 作品形式：

  -  图片：
  照片、创意海报、信息图、漫画等。有无文字皆可（图片使用gif、png、jpg或bmp格式，大小限制在4MB内）

  -  视频:
  大小需限制在1分钟内

• 材料和信息必须原创

• 作品主要语言为中文

本次大赛所有参赛作品将由专家评审委员会评估。所有参赛作品将会按照以下标准得到1-10分：1.创意性；2.传播性；3.提升乙肝、丙肝检测率的可能性。

世界卫生组织的合作伙伴为本次大赛提供了以下奖金和奖品：

每位获奖者均可获得官方证书和奖状，作品将被用作2017年“世界肝炎日”宣传材料。

一、二、三等奖获奖代表均将受邀参加2017年7月28日在北京举办的世界肝炎日活动。机票住宿费用均由世界卫生组织的合作伙伴承担。

本次大赛均通过网络投稿，点击“阅读全文”可进入作品提交页面。

更多关于挑战赛的详细信息，请登录大赛官方网站进行查询：

http://www.cfhpc.org/home/Details/3476

如有疑问，欢迎发送邮件与我们联系： 

hepatitischallenge@qq.com

本次大赛的合作伙伴有:

世界卫生组织代表处、中国疾病预防控制中心、中国肝炎防治基金会、北京市疾病预防控制中心、中华医学会肝病学分会、中华预防医学会、、吴阶平医学基金会、中联肝健康促进中心、北卡罗来纳大学教堂山分校、亚太扑灭病毒性肝炎联盟、斯坦福大学亚裔肝脏中心、赛思SESH

WHO: 2017 Hepatitis Testing Innovation Challenge 

Hepatitis B and C are the major causes of liver cirrhosis and liver cancer in China. As a result, scaling up HBV and HCV testing has become indispensible to the public health system.  However, there remains a lack of awareness among the general population and a need for more effective educational materials. To further promote HBV and HCV testing, we encourage YOU to participate in our 2017 Hepatitis Testing Innovation Challenge. By making your photo or video submission, you too, can help raise awareness, increase knowledge, address biases, and eliminate discrimination against those living with chronic hepatitis.  

Theme of Challenge

The theme of the challenge revolves around “hepatitis testing.” Submissions should aim to increase the general public’s knowledge and raise awareness of HBV and HCV, encourage and promote testing of hepatitis, and address discrimination against those with hepatitis.

Timeline

Call for Submissions: 

    March 2017—April 20, 2017 

Review of Submissions: 

    May 2017—mid-July 2017

Announcement of Results: 

    World Hepatitis Day-July 28th 2017

Submission Requirements

• Submission Format:

   -  Photo Submission (with or without text): pictures, posters, comic, infographics etc.（acceptable file types include gif, png, jpg, or bmp. Maximum 4MB）

    -  Video Submission: submissions should be kept within 1 minute.

• All material and information must be original.

• Submissions can be directed at the general public or a particular group affected by HBV/HCV.

• The main language used in submission should be Mandarin Chinese.

Selection Process

All submissions will be evaluated by a steering committee composed of academic researchers, civil society leaders, patient advocates, physician leaders, policymakers, and other key individuals. Each submission will be scored on a scale of 1-10 based on the following criteria: (1) innovation, (2) likelihood of being re-shared through social media or shown to family and peers, and (3) likelihood of increasing hepatitis B/C testing. 

Prizes and Awards

Prizes have been generously offered by partners of WHO in support of efforts that will promote awareness and reduce stigma associated with hepatitis in China.

First, Second, and Third Place winners will be invited to attend the 2017 World Hepatitis Day event held in Beijing. All accommodation and travel expenses will be covered by the partners of WHO.  

Awards of Excellency: Submissions with an overall score of 7 or higher

Award winners will receive an official certificate of recognition. Furthermore, award submissions will be used as promotional material for the 2017 World Hepatitis Day.   

How to Participate

All submissions should be made electronically. Please click on “read more” at the bottom of the page to make your submission.

For more information, please visit the official website of the Innovation Challenge:

http://www.cfhpc.org/home/Details/3476

Please forward any questions or challenge-related inquires to:

hepatitischallenge@qq.com

Partners:

WHO China Office, China CDC, Chinese Foundation for Hepatitis Prevention and Control, The University of North Carolina at Chapel Hill, Beijing CDC, Chinese Society of Hepatology, Chinese Association of STD & AIDS Prevention and Control, China Liver Health, Asian Liver Center at Stanford University, SESH, Coalition to Eradicate Viral Hepatitis in Asia Pacific, Wu Jieping Medical Foundation